SEARCH

SEARCH BY CITATION

References

  • 1
    Nomura A. Stomach cancer. In: ScohottenfeldD, FraumeniJFJr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996: 70724.
  • 2
    Blau S, Kohen R, Bass P, Rubinstein A. Relation between colonic inflammation severity and total low-molecular-weight anti-oxidant profiles in experimental colitis. Dig Dis Sci 2000; 45: 11807.
  • 3
    Correa P. The role of anti-oxidants in gastric carcinogenesis. Crit Rev Food Sci Nutr 1995; 35: 5964.
  • 4
    Swinyard EA, Lowenthal W. Pharmaceutical necessities. In: OsolA, ed. Remington pharmaceutical sciences 16th edn. Easton, Pa: Mack Publishing Co., 1980: 122527.
  • 5
    Lintner CJ. Stability of pharmaceutical products. In: OsolA, ed. Remington pharmaceutical sciences, 16th edn. Easton, Pa: Mack Publishing Co., 1980: 142529.
  • 6
    Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: a review of epidemiological evidence. Nutr Cancer 1992; 18: 1.
  • 7
    Hahm KB, Lee KJ, Kim JH, Cho SW, Chung MH. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide. Dig Dis Sci 1999; Suppl 43: 72S7S.
  • 8
    Nair S, Norkus EP, Hertan H, Pitchumoni CS. Micronutrient anti-oxidants in gastric mucosa and serum in patients with gastritis and gastric ulcer: does Helicobacter pylori infection affect the mucosal levels? J Clin Gastroenterol 2000; 30: 3815.
  • 9
    Ekström AM, Serafini M, Nyren O, Hansson LE, Ye W, Wolk A. Dietary anti-oxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case–control study in Sweden. Int J Cancer 2000; 87: 13340.DOI: 10.1002/1097-0215(20000701)87:1<133::aid-ijc20>3.3.co;2-5
  • 10
    Waring AJ, Drake IM, Schorah CJ et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996; 38: 1716.
  • 11
    Reed PI. Vitamin C, Helicobacter pylori infection and gastric carcinogenesis. Int J Vitam Nutr Res 1999; 69: 2207.
  • 12
    Schorah CJ, Sobala GM, Sanderson M, Collis N, Primrose JN. Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. Am J Clin Nutr 1991; 53: 2875934.
  • 13
    Sobala GM, Schorah CJ, Shires S et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 103841.
  • 14
    Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KEL. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 31722.
  • 15
    Buiatti E, Palli D, Decarli A et al. A case control study of gastric cancer and diet in Italy: association with nutrients. Int J Cancer 1990; 45: 896901.
  • 16
    Ruiz B, Rood JC, Fontham ETH et al. Vitamin C concentration in gastric juice before and after anti- Helicobacter pylori treatment. Am J Gastroenterol 1994; 89: 5339.
  • 17
    Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci 1995; 40: 61521.
  • 18
    Phull PS, Price AB, White KLM, Schorah CJ, Jacyna MR. Gastroduodenal mucosal vitamin-C levels in Helicobacter pylori infection. Scand J Gastroenterol 1999; 4: 3616.
  • 19
    Sanderson MJ, White KLM, Drake IM, Schorah CJ. Vitamin E and carotenoids in gastric biopsies: the relation to plasma concentrations in patients with and without Helicobacter pylori gastritis. Am J Clin Nutr 1997; 65: 1016.
  • 20
    Zhang H, Wakisaka N, Maeda O, Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer 1997; 80: 1897903.DOI: 10.1002/(sici)1097-0142(19971115)80:10<1897::aid-cncr4>3.3.co;2-9
  • 21
    Wang X, Willen R, Wadström T. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother 2000; 44: 24527.
  • 22
    Blanchard TG, Czinn SJ. Immunological determinants that may affect the Helicobacter pylori cancer risk. Int J Cancer 1997; 73: 6849.
  • 23
    Lindholm C, Quiding-Jarbink M, Lonroth H, Hamlet A, Svernnerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 596471.
  • 24
    Bennedsen M, Wang X, Willen R, Wadström T, Andersen LP. Treatment of H. pylori infected mice with anti-oxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol Lett 1999; 70: 1859.